RA Capital Management is a Boston-based investment firm that specializes in life sciences and healthcare companies. The firm provides investment management and venture capital services, backing companies developing drugs, medical devices, diagnostics, and biotech tools. Its team combines expertise in biology, chemistry, and medicine with industry and business development experience. RA Capital supports companies across multiple stages, from seed funding to growth financings, including private and public rounds, and often takes board seats and seeks co-investment opportunities. Through its activity, it aims to identify technologies with potential to advance prevention and treatment, genetic testing and personalized medicine, and other patient-focused innovations.

MassVentures is a Massachusetts-based venture capital firm that provides seed and early-stage funding to high-growth startups in the Massachusetts innovation economy, helping concepts move from idea to commercialization. Founded in 1978 as a quasi-public corporation by the Legislature of the Commonwealth, it is governed by an independent board and managed by experienced venture investors. The firm focuses on information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics sectors in Massachusetts and operates accelerator programs to support portfolio companies. MassVentures leverages the state's entrepreneurial ecosystem, educated workforce, and centers of innovation to back early-stage ventures.

Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Atlas Venture is a Cambridge, Massachusetts–based venture capital firm founded in 1980 that specializes in life sciences and technology. It pursues seed-led venture creation and early-stage investments to build scalable companies in biopharmaceuticals, diagnostics, medical devices, and related biomedical technologies, as well as software and other technology sectors. The firm often leads investments and seeks board representation to support portfolio companies as they grow toward acquisition or public offerings. Atlas operates with dedicated life sciences and technology teams and maintains an international footprint across the United States and Europe.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, established in 2013. It targets individual accredited investors who previously had limited access to venture capital by enabling alumni from top entrepreneurial schools to invest together in ventures led by fellow alumni. The firm backs companies with an alumni connection and an institutional lead investor with sector expertise. It offers focused funds that provide accredited investors access to a diversified venture portfolio by type, sector, stage, and geography. The organization engages in seed, early-stage, and late-stage pre-IPO investments across technology, consumer, financial services, health care, life sciences, and other sectors.

General Catalyst is a venture capital firm founded in 2000 that provides early-stage and growth equity investments in technology companies. It supports portfolio companies with momentum and mentorship to accelerate growth toward long-term success and typically engages across seed to growth stages, potentially taking minority or majority stakes. The firm targets a broad range of sectors enabled by software and technology, including consumer, enterprise, fintech, crypto, healthcare IT, and related areas, and maintains a multi-region presence with offices in North America and Europe to back companies as they scale globally.

Flagship Pioneering is a Cambridge, Massachusetts-based venture creation firm that conceives, creates, resources, and grows first-in-category ventures to transform human health, sustainability, and related fields. It fuses scientific discovery with entrepreneurial leadership and professional capital to systematically build companies at the frontier of biology, engineering, medicine, energy, and beyond. The firm pursues ambitious, seemingly unreasonable propositions and steers them through an evolutionary development process to achieve transformational outcomes. By combining deep scientific insight with a structured, capital-backed platform, Flagship Pioneering accelerates progress in health technology, biotechnology and life sciences.

Founder Collective is a seed- and early-stage venture capital firm founded in 2009 by entrepreneurs who have built and exited technology companies. Headquartered in Cambridge, Massachusetts, with an office in New York, the firm makes early investments across the United States and globally. It is industry-agnostic but prefers ventures with an information technology component, including software and TMT-enabled businesses. The firm focuses on supporting founders at the seed and early stages, drawing on the experience of its partners who have firsthand startup experience.

Accomplice is a seed-led venture capital firm based in Cambridge, Massachusetts, focused on early-stage technology startups. It invests in cybersecurity, eSports, data analytics, SMB-class software, emerging hardware platforms, and marketplaces. The firm pursues a community-driven approach, leveraging platforms such as AngelList, Boston Syndicates, Maiden Lane, Spearhead, BOSS, Rev, and TUGG to identify and support founders. While most investments are in Boston, its portfolio spans the United States, Canada, and Europe, reflecting an active geographic reach in New England and beyond.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

ARCH Venture Partners is a United States-based venture capital firm founded in 1986 and headquartered in Chicago, Illinois. The firm focuses on science-driven companies, with a track record of commercializing technologies developed at academic research institutions and national laboratories. It primarily invests in life sciences, biotechnology, pharmaceuticals, healthcare technology, and related sectors, and also backs software, materials, clean tech, and information technology across early to growth stages. ARCH emphasizes relationships with scientists and entrepreneurs, often taking early stakes and supporting subsequent rounds to help market entry and scale. The firm has raised multiple venture funds totaling several billion dollars and maintains a national and international reach with offices across North America.

Mission BioCapital is a life science venture capital firm that backs early‑stage biotechnology companies. Based in Cambridge, Massachusetts, the firm draws on a leadership team with a long history of investing in and launching numerous early‑stage life science ventures. It operates in regions with strong research, discovery, and venture capital ecosystems and is known for providing deep expertise and active support to its portfolio companies.

F-Prime Capital is a venture capital investment firm based in Cambridge, Massachusetts. Founded in 1969 with roots in Fidelity Investments, it backs entrepreneurs across technology and life sciences, investing in sectors such as crypto, enterprise information technology, fintech, frontier technologies, health information technology and services, medtech and therapeutics, with a global reach across the Americas, Europe and Asia.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

Matrix Partners is a San Francisco-based venture capital firm founded in 1977 that backs technology companies from idea through Series A and beyond. The firm focuses on software, AI, B2B, consumer, fintech, health tech, infrastructure, and related sectors, with a global footprint in the United States, India, and China. Its team comprises former founders and operators who work closely with portfolio companies and often join boards to support growth. Matrix Partners has backed a broad slate of successful companies in its decades-long history, including Apple, FedEx, Oculus, Zendesk, HubSpot, Canva, and Postmates, illustrating a pattern of helping developers and builders scale toward IPO or strategic exits. The firm's China arm extends its early-stage and growth investments in the Chinese market, reinforcing its international reach.

OrbiMed is a healthcare-focused investment firm based in New York, founded in 1989, with approximately $5 billion in assets under management. It engages in private equity, venture capital, and growth investments across the global healthcare landscape, spanning biopharmaceuticals, biotechnology, life sciences tools, medical devices, diagnostics, health care services, and digital health. The firm invests across the development spectrum, from startup ventures to mature companies, and pursues opportunities worldwide, including North America, Europe, Asia, Israel and India, leveraging a long-standing specialization in the sector. Through its diversified capital programs, OrbiMed partners with management to advance innovative therapies, tools, and services that address significant medical needs.

Insight Partners is a global software investor that partners with growth-stage technology and software companies. Headquartered in New York City with offices in London, Tel Aviv, and Palo Alto, it concentrates on growth-stage software, internet, and data services, with notable focus areas including fintech, cybersecurity, AI/ML, DevOps, and healthcare. Founded in 1995, Insight Partners manages over $75 billion in regulatory assets under management and has invested in more than 750 companies worldwide, with over 55 portfolio companies achieving an IPO. The firm combines capital with hands-on, right-sized software expertise to support portfolio companies on their growth journey from first investment to IPO.

Casdin Capital is a New York-based investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin, the firm pursues private investments and research-driven opportunities across early- to late-stage companies in these sectors and is described as a venture capital firm and a registered investment adviser.

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines across neuroscience, cardiometabolic diseases, cancer, and immunology. It operates manufacturing and research facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The portfolio includes Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant, reflecting a diversified, science‑driven approach. In addition to human medicines, Lilly conducts research in animal health to treat animal diseases and support agricultural productivity. The company maintains a strong emphasis on research and development to address unmet medical needs and to bring innovative therapies to patients worldwide.

Spark Capital is a venture capital firm founded in 2005 with offices in San Francisco, Boston, and New York City. It focuses on early-stage investments across technology-enabled sectors, supporting founders with flexible, founder-centric backing. The firm has backed high-profile consumer and software companies such as Twitter, Discord, Oculus, Warby Parker, Tumblr, Niantic, and Anthropic, reflecting a tendency toward ambitious products and teams that reshape consumer, media, and technology markets.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. The firm backs entrepreneurs with venture assistance, strategic guidance, and capital, focusing on bold, early-stage technology companies. It invests across sectors including AI, climate and sustainability, enterprise software, consumer technologies, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technologies. Based in Menlo Park, the firm manages several funds to support startups across stages, prioritizing ventures that address large markets and have potential for significant social and economic impact.

Launchpad Venture Group is an angel investment group and venture capital firm based in Boston, Massachusetts, that provides funding to early-stage technology and life sciences companies in the United States. It backs software, information technology, web, e-commerce, media and social media, mobile and wireless, medical devices, diagnostics, healthcare IT, networking and telecom, clean-tech, renewable energy and green-tech sectors. The firm seeks innovative startups addressing significant market opportunities and supports them with human and financial capital, leveraging its connections to customers, service providers, partners, and future sources of financing to help entrepreneurs build successful companies.

.406 Ventures is a Boston-based venture capital firm founded in 2005 that specializes in early-stage investing in enterprise information technology and services. The firm backs B2B software, cybersecurity, IT security and infrastructure, data and cloud technologies, technology-enabled business services, digital health, fintech, big data, and artificial intelligence, with a geographic focus on the Northeast United States. It often acts as lead or first institutional investor in de novo and early-stage rounds and supports portfolio companies through growth with follow-on investments. Typical initial commitments range from 2 to 5 million dollars, with total investments of about 6 to 10 million per company. The team emphasizes practical industry experience and networks to help companies scale.

NextView Ventures is a Boston- and New York-based venture capital firm founded in 2010 that focuses on seed and early-stage investments across a broad set of sectors including fintech, software, B2B and consumer technologies, health, and internet-enabled businesses. The firm operates on a hands-on, high-conviction approach, often taking a lead or board role in portfolio companies and supporting them through early growth. It targets U.S. startups, with a notable emphasis on the Boston and New York ecosystems, and maintains an accelerator program that provides investment and guidance to a small number of pre-seed and seed ventures. NextView emphasizes thematic investing and aims to help entrepreneurs build companies of significance to shape a future of collective prosperity.

SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995, that focuses on seed to growth investments in deep technology across health, environmental tech, hardware, robotics, and cross border software, with a particular emphasis on Asia. The company runs accelerator style startup development programs, including HAX and IndieBio, which provide facilities, engineering resources, and lab equipment to help founders accelerate product development, acquire customers, and attract later stage funding. SOSV pursues a limited number of high potential startups, offering extensive hands on support to speed commercialization and scale, and aims to back innovations that improve human and planetary health.

SV Health Investors is a United States‑headquartered healthcare and life sciences venture capital and growth equity firm. Formerly known as SV Life Sciences, it supports entrepreneurs who create breakthrough companies and treatments across biotech, medical devices, and healthcare services. With offices in Boston, San Francisco and London, the firm has over two billion dollars of capital under management across seven private healthcare funds and more than two decades of activity in the US and Europe.

Pillar VC is a Boston-based venture firm founded in 2016 that provides early-stage capital to technology-focused startups. It supports founders from inception with initial funding and ongoing resources, including connections, coaching, and a collaborative community, to help companies grow. The firm backs a broad range of ventures—from university spinouts led by first-time founders to serial entrepreneurs—across sectors such as software as a service, artificial intelligence and machine learning, hardware, enterprise software, blockchain and quantum technologies, digital health, and synthetic biology, as well as fintech, life sciences, robotics, drones, manufacturing, agtech, logistics, and information technology. Pillar VC pursues high-potential ventures at early stages and emphasizes building long-term value for its portfolio.

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland, with additional offices in San Francisco and Cambridge. Founded in 2018, the firm invests in life sciences and technology companies across biotechnology, diagnostics, digital health, environmental technologies, and related industries, including AI and machine learning-enabled therapeutics and medical technologies. It targets growth capital and early-stage opportunities, providing capital and strategic support to help scientific innovations reach the market. The firm operates as a registered investment adviser.

E14 Fund is a venture capital firm based in Cambridge, Massachusetts, focusing on seed-stage investments in deep technology sectors and related software, often originating from MIT. It supports early-stage companies by providing financing typically in the 0.5 to 1 million dollar range per company and leveraging a network of investors, industry experts, and entrepreneurs to move technologies from lab to market. The firm backs ventures across fields including biotechnology, smart cities, consumer electronics, and manufacturing, and serves as a bridge connecting MIT founders with capital and strategic guidance. It emphasizes diversity and inclusion, noting that a significant share of its portfolio founders are female and originate from outside the United States.

Hyperplane Venture Capital is a Boston-based early-stage venture capital firm that funds technology startups. The firm focuses on machine intelligence and data companies, backing founders who leverage AI, sensor technology, and cloud computing to tackle difficult problems and build software and data-driven businesses. Hyperplane seeks exceptional teams and aims to advance solutions at the intersection of perception, communication, intelligence, and insight.

Highland Europe is a venture capital firm focused on growth-stage investments in European internet, mobile and software companies, with emphasis on consumer and enterprise technology. Headquartered in London, it targets rapidly expanding European businesses and provides growth capital to accelerate scale and build lasting value. The firm typically makes equity investments in the €5 million to €75 million range and supports companies with revenue around €10 million, while maintaining a Europe-wide focus with a Geneva presence. Established in 2012, Highland Europe operates in collaboration with Highland Capital Partners to leverage extensive investment experience across the technology sector.

Third Rock Ventures is a Boston-based venture capital firm focused on investing in life sciences and healthcare companies in the United States. It backs startups developing medicines, diagnostics, medical devices, and related technologies with high growth potential, often providing substantial initial capital and strategic collaborations to advance development. The firm takes an active role in portfolio companies, frequently leading investment rounds and sometimes assuming key management positions, and collaborates with larger pharmaceutical and biotechnology companies. Since its founding in 2007, Third Rock has supported firms across biotechnology, therapeutics, oncology, medical devices, and data-driven life sciences, aiming to bring transformational healthcare innovations to market. The firm operates primarily from Boston with additional presence in San Francisco.

Samsara BioCapital is a Palo Alto-based venture capital firm founded in 2016 that focuses on the healthcare sector, including biotechnology, pharmaceuticals, oncology, and life sciences. The firm seeks opportunities in the United States and provides investment advisory services as part of its activities, supporting companies developing innovative therapies and related technologies.

Safar Partners is a venture capital investment firm based in Cambridge, Massachusetts, founded in 2018. It focuses on seed- to growth-stage technology startups, with a track record of supporting companies connected to institutions such as MIT, Harvard, and the University of Rochester. The firm targets opportunities in cleantech and advanced materials, artificial intelligence and information technology, robotics, and life sciences or medical devices, prioritizing investments in the United States. Safar Partners operates as a registered investment adviser.

Walnut Venture Associates is a Massachusetts-based venture capital firm focused on seed and early-stage information technology companies in New England. Based in Boston, it typically invests 250,000 to 1,000,000 per financing and seeks board representation in portfolio companies, providing active involvement and strategic support. The firm helps entrepreneurs refine business plans, assemble management teams, develop financing strategies, and establish strategic partnerships, leveraging the experience of a group of seasoned entrepreneurs and investors. One member often serves on the board, while the full capabilities of the group are available to portfolio companies.

LaunchCapital is a venture capital firm based in New Haven, Connecticut, that funds seed and early-stage startups. It focuses on technology, consumer, and medical sectors and targets commerce, marketplaces, media and entertainment, enterprise software and services, data, finance, healthcare, and emerging technologies. The firm maintains offices in Boston, New York, New Haven, and San Francisco and pursues opportunities for exponential growth by providing equity investments and other capital support to startups in the initial development stage. By helping founders scale from concept to revenue, LaunchCapital aims to optimize early-stage capital structures and support sustainable growth for portfolio companies.

Bessemer Venture Partners is a global venture capital firm founded in 1911 and headquartered in Redwood City, California. It backs startups across seed to growth stages, focusing on software, cloud, cybersecurity, fintech, consumer and healthcare technologies, and high-growth business models. The firm operates internationally, supporting portfolio companies from early product development through scale, and has backed well-known names such as Pinterest, Shopify, Twilio, Yelp, LinkedIn, Wix and others. BVP emphasizes helping founders establish durable foundations and guides companies through multiple growth phases, leveraging hands-on operational support, strategic networks, and cross-border expertise. With a diversified approach that includes consumer, enterprise and deep-tech investments, the firm seeks to build lasting companies that matter across global markets.

Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage technology and healthcare investments and has backed landmark companies such as Apple Computer, Intel, Illumina, Gilead Sciences, Athenahealth, DoubleClick, Nest, SlideShare, and Tudou. The firm manages multiple funds and maintains a US-focused investment approach, supporting entrepreneurs across information technology, life sciences, and related sectors throughout their growth journey.

Underscore.VC is a Boston-based venture capital firm founded in 2015 that invests from seed through growth stages across the United States. It backs technology companies in sectors such as enterprise software, artificial intelligence and machine learning, fintech, insurtech, healthtech, e-commerce, the Internet of Things, and web3/blockchain, as well as data infrastructure, cloud software, and sensor-enabled industrial and home automation applications. With a focus on supporting bold entrepreneurs, the firm provides capital and strategic guidance to help startups accelerate product development and scale operations from pre-seed to Series A and beyond.

Deerfield Management is a New York-based investment management firm founded in 1994 that focuses on healthcare. It engages in long-term structured investments in both public and private healthcare companies, and operates across investment activities, information services, and philanthropy. It acts as an investment adviser and supports private and public investments across life sciences, medical devices, diagnostics, digital health, and health services.

Battery Ventures is a technology-focused venture capital firm based in Boston, Massachusetts, founded in 1983. It invests in category-defining technology companies across sectors such as application software, infrastructure software, consumer internet and mobile services, industrial technologies, and life science tools. The firm supports growth across various stages and geographies, including the United States, Europe, and Israel, with emphasis on software, TMT, and related tech-enabled opportunities. As a registered investment adviser, Battery Ventures backs companies that build scalable platforms and transformative products, helping them compete in rapidly evolving markets.

Connecticut Innovations is a venture capital organization based in New Haven, Connecticut. Founded in 1989, it provides strategic capital and operational insight to innovative companies across Connecticut, with investments spanning seed to later stages in sectors including software as a service, manufacturing, life sciences, clean tech, oncology, cybersecurity, infrastructure, big data, e-commerce, and technology driven industries such as energy, information technology, and photonics. The organization supports portfolio companies through flexible financing, strategic guidance, and introductions to partners and resources within the Connecticut ecosystem.

Novo Nordisk is a global healthcare company that develops, manufactures, and distributes insulin and other diabetes medicines to treat chronic diseases. It pursues scientific breakthroughs and aims to expand access to its medicines, with the ultimate goal of preventing and curing disease.

5AM Ventures is a San Francisco-based venture capital firm founded in 2002 by John Diekman and Andrew Schwab. The firm specializes in seed- and early-stage investments in life sciences and healthcare, including biopharmaceuticals, medical technology, digital health, and research instrumentation, with activity across the United States and North America. It supports early companies through strategic financing and guidance to help advance innovative therapies and health-related technologies.

Refactor Capital is a Burlingame, California-based venture capital firm focusing on seed- and early-stage investments in hard technology, biotechnology, health, climate, and related sectors. The firm is led by Zal Bilimoria, a former partner at Andreessen Horowitz and a veteran product and engineering executive with experience at Google, Netflix, and LinkedIn, who typically leads seed rounds with checks in the 1–2 million range.

Clean Energy Ventures is a Boston-based venture capital firm that invests in seed- and early-stage climate technology startups across North America, Europe and Israel. It focuses on advancing energy storage, grid connectivity, renewable energy production, clean transportation, and the water–energy nexus, supporting technologies and business models with scale potential to reduce greenhouse gas emissions. The firm backs companies that address climate change through market-driven approaches and seeks to accelerate commercialization of disruptive clean energy innovations.

Innospark Ventures is a Boston-based venture capital firm founded in 2018 that concentrates on seed and early-stage investments in artificial intelligence and technology-driven startups. It backs companies across AI applications and related sectors, including healthcare, life sciences, enterprise software, education, cybersecurity, and business services, with a focus on impact-driven AI solutions in Boston and the broader New England region. Typical investment sizes range from $0.5 million to $5 million.

Boston Seed Capital is a venture capital firm focused on seed- and early-stage investments in internet-enabled and technology-driven companies. Founded in 2010 and headquartered in Boston, Massachusetts, with an office in Wellesley Hills, it backs startups across the United States in consumer goods, business services and technology, including information technology, software and SaaS, cybersecurity, e-commerce, big data, marketplaces, and artificial intelligence and machine learning.

Pfizer is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines across a broad range of therapeutic areas. It maintains an extensive portfolio of prescription drugs and vaccines, with notable products such as Prevnar 13, Ibrance, and Eliquis. The company serves customers worldwide, with substantial international and emerging-market sales. Through ongoing research and development, Pfizer pursues new treatments to address major diseases, including cancer and neurodegenerative conditions, and aims to improve patient outcomes by delivering safe, effective, and accessible therapies. Founded in 1849 and headquartered in the United States, Pfizer operates globally to advance health care through science, partnerships, and scalable manufacturing capabilities.